American Biosurgical announces acquisition of MTI

NewsGuard 100/100 Score

American Biosurgical, LLC ("ABI") (www.americanbiosurgical.com) a privately owned, custom medical cable manufacturer actively engaged in the design, development and production of innovative medical interconnect technologies for the world's leading medical device companies has announced the acquisition of MTI Corporation, a high precision, low volume custom medical cable manufacturer based in North Carolina. The new business will retain the MTI brand under the name MTI Medical Cables.

The acquisition expands ABI's customer base; and introduces a new product segment, pressure transducer monitoring, within the patient monitoring market. With MTI's production facility in Asheville, North Carolina, American Biosurgical adds US manufacturing capabilities to complement its existing overseas manufacturing in China.

"We are excited about this acquisition," said ABI's President and CEO, Jim Martin. "This strategic move provides us with a stronger presence in North America and will help us diversify our customer base and product mix. MTI has a long history with key customers who have already expressed excitement about our capabilities to produce high volume, low cost cables for them through our overseas factories. We will continue to pursue acquisition targets similar to MTI as we expand our footprint in the U.S."

Source:

American Biosurgical

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
LGM Pharma unveils enhanced analytical testing services and expands CDMO portfolio with additional suppository manufacturing capabilities